.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Moodys
Argus Health
Julphar
UBS
Medtronic
US Army
Teva
Cerilliant

Generated: January 21, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: remifentanil hydrochloride

« Back to Dashboard

Midazolam
CASRN: 59467-70-8UNII:

Manufacturing Methods

<truncated in preview>

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Cerilliant
Novartis
AstraZeneca
Dow
Daiichi Sankyo
Cipla
QuintilesIMS
Citi
Baxter

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot